U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509541) titled 'Hemodynamic and Respiratory Instability During Percutaneous Pulmonary Thrombectomy' on March 29.
Brief Summary: Pulmonary embolism (PE) is a potentially life-threatening condition caused by the obstruction of pulmonary arteries by thrombi. Patients with high-risk or intermediate-high-risk PE may require immediate reperfusion therapies, including percutaneous pulmonary thrombectomy. However, this procedure can be associated with significant hemodynamic and respiratory instability, potentially leading to shock, cardiac arrest, or the need for advanced support such as mechanical ventilation or extracorporeal membrane oxygenation (ECMO)...